DoW Autism Career Development Award

The Autism Research Program Career Development Award is offered by the Defense Health Agency through the Congressionally Directed Medical Research Programs. This initiative is part of a broader federal effort to advance high-impact biomedical research that improves outcomes for individuals with autism and their families. Established by congressional appropriation, the Autism Research Program has funded significant research since 2007 and continues to emphasize innovation, translational relevance, and community engagement. The Career Development Award specifically targets investigators at critical career transition points, including early-stage independent researchers and established scientists entering the autism research field. The primary purpose of this funding opportunity is to support innovative, high-impact research projects or early-phase clinical trials that demonstrate strong potential to improve understanding, diagnosis, treatment, or quality of life for individuals with autism. Applicants are encouraged to align their proposals with defined areas of interest such as therapeutic development, service delivery improvements, environmental risk factors, and lifespan-related challenges. Projects must clearly articulate their anticipated impact on both scientific knowledge and real-world outcomes for the autism community. A strong emphasis is placed on collaboration, particularly with community stakeholders, including autistic individuals, caregivers, or advocacy organizations. Funding for this opportunity is limited, with approximately $1.5 million allocated to support around two awards. Each award has a maximum total cost cap of $750,000 over a performance period of up to three years. Funds may be used for a variety of research-related expenses including personnel, travel for collaboration and dissemination, and participant-related costs such as compensation and accessibility support. However, certain restrictions apply, such as limits on travel funding and prohibitions on specific types of animal research. Cost sharing is not required, making this a fully federally funded opportunity without matching obligations. Eligibility is broad in terms of institutional participation, allowing both domestic and international organizations, including academic institutions, nonprofit entities, for-profit companies, and government agencies. However, eligibility for principal investigators is more narrowly defined. Applicants must be independent investigators at or below the level of Assistant Professor, or established researchers transitioning into autism research. Additional restrictions include limits on prior funding history in autism research and a prohibition on individuals who have previously received similar career development awards from federal agencies. The application process follows a two-step submission model. First, applicants must submit a pre-application through the Electronic Biomedical Research Application Portal. This preproposal includes a concise narrative outlining the investigator’s qualifications, research concept, and potential impact. Only selected applicants are invited to submit a full application, which requires extensive documentation including a detailed project narrative, technical and lay abstracts, budget forms, letters of support, and multiple compliance-related attachments. Full applications are submitted through Grants.gov or eBRAP depending on the applicant’s institutional type. Applications undergo a rigorous two-tier review process. The first tier, peer review, evaluates scientific merit, study design, feasibility, and potential impact. The second tier, programmatic review, considers alignment with program priorities and overall portfolio balance. Evaluation criteria include scientific rigor, innovation, investigator potential, and the strength of the research team. For projects involving clinical trials, additional scrutiny is applied to regulatory readiness, ethical considerations, and community collaboration plans. Key deadlines for this funding cycle include a pre-application submission deadline of July 27, 2026, and a full application deadline of October 22, 2026. Invitations to submit full applications are expected by late August 2026, with peer review occurring in December 2026 and programmatic review in February 2027. Awards are anticipated to be finalized by September 2027. The program does not explicitly state recurrence, but as part of an annual federal appropriations process, similar funding opportunities may be released in future fiscal years. Applicants are encouraged to monitor updates and prepare early due to the complexity and competitiveness of the process.

Strongly align with defined areas of interest and clearly articulate impact; include meaningful community collaboration; ensure rigorous statistical and study design; demonstrate PI career development trajectory